Development of an IGF1R longevity variant mouse line using CRISPR/Cas9 genome editing.
Dou Y, Darvas M, Sharma K, Mathieu J, Morton J, Tan H, Soto-Palma C, Angelini LA, McGowan SJ, Niedernhofer LJ, Suh Y, Robbins PD, Barzilai N, Ladiges WC. Development of an IGF1R longevity variant mouse line using CRISPR/Cas9 genome editing. Trends Biomed Res. 2020 Dec; 3(1).